← Eichor
Condition: Cll Variant Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Cll Variant

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Intermittent Versus Continuous Venetoclax With Acalabrutinib for CLL/SLL
Phase 2 · 1 location(s) · Zulfa Omer · NCT07014917Study of Epcoritamab as a Consolidation Therapy in CLL/SLL
Phase 2 · 1 location(s) · Zulfa Omer · NCT07108998LP-168 and Obinutuzumab for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Variants of This
Phase 2 · 1 location(s) · Zulfa Omer · NCT06978088
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.